Metabolic engineering is defined as the application of recombinant DNA technology to increase biological activity by manipulating the cell's enzymatic, transport, and regulatory processes. The purposeful manipulation of cellular metabolism for the generation of desired substances is known as metabolic engineering. The metabolic pathways of numerous species can be modified using recombinant DNA technology. Bacteria, fungi, plants, and mammal cells are all employed as host organisms, and the features of interested pathways are used to guide selection. The generation of PHAs in diverse microbes has advanced significantly owing to metabolic engineering. In addition to metabolic engineering, systems biotechnology has enabled the collection and analysis of extensive data from biological systems, providing for a degree of insight previously unreachable for the development of computer models. The ultimate goal of metabolic engineering is to be able to harness these organisms to create valuable compounds in a cost-effective manner on an industrial scale. Beer, wine, cheese, pharmaceuticals, and other biotechnology products are current examples. (1) overexpressing the gene encoding the biosynthetic pathway's rate-limiting enzyme, (2) inhibiting competing metabolic pathways, (3) heterologous gene expression, and (4) enzyme engineering is some of the main metabolic engineering procedures.
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Bioherbicides for eco-friendly weed management: From fields to commercialization, constraints and solutions for sustainable agriculture
K R Aneja, Kurukshetra University, India
Title : Predicting wound closure and future segmentation masks in wound healing assays
Alfredo De Cillis, Univeristy of Salento, CNR Nanotec, Italy
Title : Utilizing complex coacervation to promote the controlled crystallization of hydrophobic drugs
Anvesha Subramanian, University of Houston, United States
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States